Global Hospital Acquired Disease Testing Market || keyplayers Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid.

Hospital-acquired infections (HIA) are caused due to viral, bacterial, and fungal pathogens. Infection developed at a certain location such as hospitals due to presence of toxins is called as nosocomial infection or hospital acquired infections. Patients with compromised immune systems are at high risk of developing infection during their hospital stays. Infection can occur by several modes, which include healthcare staff, contaminated medical equipment, bed linens or air droplets. Also, infection can originate from the outside environment, another infected patient, staff that may be infected with unknown pathogen. Hospital acquired infections could be catheter-related bloodstream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection.

Download Free sample copy of this report @
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/98

Improper infection control practices and procedures at healthcare center and unclean and non-sterile environmental surfaces lead to development of hospital acquired diseases, which is driving growth of the hospital acquired disease testing market. Furthermore, increasing antibiotic resistance due to adoption of advanced medical care results into development of hospital acquired diseases, which in turn is fueling growth of the market. Moreover, increasing prevalence of nosocomial infections such as surgical wounds, urinary tract infections, and lower respiratory tract infections in intensive care units, orthopedic, and acute surgical ward are driving growth of the market.

Hospital acquired infection is a major burden for society, patients, and healthcare management. Increasing awareness among population regarding hospital acquired infections, adoption of infection control programs by healthcare facilities, maintaining personal hygiene by the hospital staff, complete sterilization of medical equipment, and a clean sanitary environment in the health care facilities may restrain growth of the hospital acquired disease testing market.

Hospital acquired disease testing market is segmented on the basis of test type and region. On the basis of test type, the market is segmented into urinary tract infection, surgical site infection, pneumonia, blood stream infection, methicillin-resistant staphylococcus aureus, and others. On the basis of region, the market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa.

The key players operating in the hospital acquired disease testing market include Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid.

Contact Us:
Mr Alex (Sales Manager)
Prophecy Market Insights
Phone: +91 777 504 9802
+1 860 531 2701
Email: sales@prophecymarketinsights.com

About us:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

This release was published on openPR.